Lithuania Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports

Lithuania Pharmaceuticals and Healthcare Report

Lithuania Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports
Lithuania Pharmaceuticals and Healthcare Report
Published Aug 27, 2016
80 pages — Published Aug 27, 2016
Price US$ 1,295.00  |  Buy this Report Now

About This Report

  
Abstract:

In BMI s Q--- Pharmaceutical Risk/Reward Index (RRI) Lithuania is ranked --th out of the -- markets in the Central and Eastern European (CEE) matrix with an unchanged score of --.- from with the previous quarter. Lithuania scores slightly above the regional average score of --.- in Q---. ...In BMI s Q--- Pharmaceutical Risk/Reward Index (RRI) Lithuania is ranked --th out of the -- markets in the Central and Eastern European (CEE) matrix with an unchanged score of --.- from with the previous quarter. Lithuania scores slightly above the regional average score of --.- in Q---. The country s overall Rewards score of --.- is below the regional average (--.-) despite a higher-than-average Country Rewards score; its Industry Rewards score is low because the small population size will continue to be an absolute limit in terms of the pharmaceutical market size and in determining longer-term opportunities. ...Lithuania scores slightly above the regional average score of --.- in Q---. The country s overall Rewards score of --.- is below the regional average (--.-) despite a higher-than-average Country Rewards score; its Industry Rewards score is low because the small population size will continue to be an absolute limit in terms of the pharmaceutical market size and in determining longer-term opportunities.

...The generic drugs sector is likely to remain strong, given harsh constraints on government spending and limited means for out-of-pocket spending. Potential for growth in spending on innovative medicines, with an ageing demographic profile and growing levels of health awareness in the country. ...The generic drugs sector is likely to remain strong, given harsh constraints on government spending and limited means for out-of-pocket spending. Potential for growth in spending on innovative medicines, with an ageing demographic profile and growing levels of health awareness in the country. Falling unemployment and rising wages to provide boost to consumer healthcare spending on over-the-counter medicines. ...Falling unemployment and rising wages to provide boost to consumer healthcare spending on over-the-counter medicines. Combined procurement with Baltic States of Estonia and Latvia to present an opportunity for larger volume purchasing albeit for discounts.

...Weaknesses Absolute size of pharmaceutical market is small. Government cost controls have had a major impact on market performance in recent years, with the reference-pricing system introduced in ---- recently modified to include therapeutic pricing and more reference countries. ...

  
Source:
Document ID
1748-202X
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Business Monitor International - Industry Reports—Established in 1984, Business Monitor International is a leading online publisher of specialist business information on global emerging markets. Business Monitor's range of quarterly services covers political risk, finance, macroeconomic performance, outlook and forecast, industry sectors and the business operating environment. Each Industry Report has been researched at source, and features latest-available data covering production, sales, imports and exports; 5-year industry forecasts through end-2012; company rankings and competitive landscapes for multinational and local manufacturers and suppliers; and analysis of latest industry developments, trends and regulatory changes.

About the Author


Cite this Report

  
MLA:
Business Monitor International - Industry Reports. "Lithuania Pharmaceuticals and Healthcare Report" Aug 27, 2016. Alacra Store. Dec 06, 2016. <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Lithuania-Pharmaceuticals-and-Healthcare-Report-2026-294>
  
APA:
Business Monitor International - Industry Reports. (2016). Lithuania Pharmaceuticals and Healthcare Report Aug 27, 2016. New York, NY: Alacra Store. Retrieved Dec 06, 2016 from <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Lithuania-Pharmaceuticals-and-Healthcare-Report-2026-294>
  
US$ 1,295.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.